Skip to main content

Enhertu for HER2-low metastatic breast cancer is a drug that could extend thousands of lives. In 2024, it was rejected for being too expensive. But after more than 2 years of relentless campaigning alongside our supporters, METUPUK and Make 2nds Count, Enhertu will finally be made available to people on the NHS in England.

What we achieved together

Over the course of the campaign, we launched two petitions, supported an Early Day Motion (EDM) and held a stunt in London’s Trafalgar Square, calling on NICE, NHS England and the drug companies to reach a deal to make Enhertu available.

Together, our two petitions gathered more than 385,000 signatures, while 65 MPs backed the EDM. This helped build the sustained pressure that was critical to securing a deal.

Thank you everybody who added their name, contacted their MPs, took part in the stunt or shared the campaign. We couldn’t have done this without you.

A selfie of Kathryn sitting beside a river with her daughter, smiling.

It’s hard to express how pleased I am to see Enhertu finally approved for use on the NHS today. This decision brings a renewed sense of hope, not only for me but for thousands of other women living with incurable HER2-low metastatic cancer. Hope of more precious time with our loved ones, hope I may still be here to support my 9 year old daughter into high school.

Kathryn
Enhertu campaigner

What about Wales, Northern Ireland and Scotland?

NICE decisions are usually adopted by Wales and NorthernIreland.Wenow needboth nations to act quickly to makeEnhertu availablefor use on the NHS, so that people can access the treatment where they live in the UK.

Enhertu for HER2-low metastatic breast cancer was approved for use on the NHS in Scotland in December 2023.

Help us fix the system

Weredetermined tokeep pushing for everyone with metastatic breast cancer to get the best possible treatment, as quickly as possible, wherever they live.

That’s whywellcontinue calling on thegovernment, NICE, NHS England and the pharmaceutical industry to work together to fixthisbrokensystemand make sure this never happens again.

Sign up for campaign updates to find out how you can help.